Systems and methods for analyzing circulating tumor dna
AssigneeSeven Bridges Genomics Inc.
InventorsWan-Ping Lee, Devin Locke
Life of this patent
Estimating the term…
Abstract
The invention provides oncogenomic methods for detecting tumors by identifying circulating tumor DNA. A patient-specific reference directed acyclic graph (DAG) represents known human genomic sequences and non-tumor DNA from the patient as well as known tumor-associated mutations. Sequence reads from cell-free plasma DNA from the patient are mapped to the patient-specific genomic reference graph. Any of the known tumor-associated mutations found in the reads and any de novo mutations found in the reads are reported as the patient’s tumor mutation burden.
Claims21
1-20. (canceled)
A method for monitoring a tumor of a patient over time, the method comprising:
- using at least one computer hardware processor to perform:
- creating, in at least one non-transitory computer-readable storage medium, a patient-specific genomic reference graph that represents at least one non-tumor sequence previously obtained by sequencing non-tumor DNA from the patient, the patient-specific genomic reference graph comprising a directed acyclic graph having nodes and edges connecting the nodes, the nodes including a first node and a second node, wherein:
- the first node is stored as a first object in the at least one non-transitory computer-readable storage medium,
- the second node is stored as a second object in the at least one non-transitory computer-readable storage medium, and
- a first edge of the edges is stored as a pointer from the first object to the second object in the at least one non-transitory computer-readable storage medium;
- aligning a first set of sequence reads, previously obtained by sequencing a first sample containing cell-free plasma DNA from the patient, to the patient-specific genomic reference graph to identify a first population of one or more mutations in the cell-free plasma DNA relative to the at least one non-tumor sequence from the patient;
- aligning a second set of sequence reads, previously obtained by sequencing a second sample containing the cell-free plasma DNA from the patient, to the patient-specific genomic reference graph to identify a second population of one or more mutations in the cell-free plasma DNA relative to the at least one non-tumor sequence from the patient, wherein the first sample was obtained at a first time and the second sample was obtained at a second time after the first time;
- and
- generating a report indicating a comparison between the first population of one or more mutations and the second population of one or more mutations.
At least one non-transitory computer-readable storage medium storing processor-executable instructions that, when executed by at least one computer hardware processor, cause the at least one computer hardware processor to perform a method for monitoring a tumor of a patient over time, the method comprising:
- creating, in the at least one non-transitory computer-readable storage medium, a patient-specific genomic reference graph that represents at least one non-tumor sequence previously obtained by sequencing non-tumor DNA from the patient, the patient-specific genomic reference graph comprising a directed acyclic graph having nodes and edges connecting the nodes, the nodes including a first node and a second node, wherein:
- the first node is stored as a first object in the at least one non-transitory computer-readable storage medium,
- the second node is stored as a second object in the at least one non-transitory computer-readable storage medium, and
- a first edge of the edges is stored as a pointer from the first object to the second object in the at least one non-transitory computer-readable storage medium;
- aligning a first set of sequence reads, previously obtained by sequencing a first sample containing cell-free plasma DNA from the patient, to the patient-specific genomic reference graph to identify a first population of one or more mutations in the cell-free plasma DNA relative to the at least one non-tumor sequence from the patient;
- aligning a second set of sequence reads, previously obtained by sequencing a second sample containing the cell-free plasma DNA from the patient, to the patient-specific genomic reference graph to identify a second population of one or more mutations in the cell-free plasma DNA relative to the at least one non-tumor sequence from the patient, wherein the first sample was obtained at a first time and the second sample was obtained at a second time after the first time;
- generating a report indicating a comparison between the first population of one or more mutations and the second population of one or more mutations.
A system, comprising:
- at least one computer hardware processor;
- and
- at least one non-transitory computer-readable storage medium storing processor-executable instructions that, when executed by the at least one computer hardware processor, cause the at least one computer hardware processor to perform a method for monitoring a tumor of a patient over time, the method comprising:
- creating, in the at least one non-transitory computer-readable storage medium, a patient-specific genomic reference graph that represents at least one non-tumor sequence previously obtained by sequencing non-tumor DNA from the patient, the patient-specific genomic reference graph comprising a directed acyclic graph having nodes and edges connecting the nodes, the nodes including a first node and a second node, wherein:
- the first node is stored as a first object in the at least one non-transitory computer-readable storage medium,
- the second node is stored as a second object in the at least one non-transitory computer-readable storage medium, and
- a first edge of the edges is stored as a pointer from the first object to the second object in the at least one non-transitory computer-readable storage medium;
- aligning a first set of sequence reads, previously obtained by sequencing a first sample containing cell-free plasma DNA from the patient, to the patient-specific genomic reference graph to identify a first population of one or more mutations in the cell-free plasma DNA relative to the at least one non-tumor sequence from the patient;
- aligning a second set of sequence reads, previously obtained by sequencing a second sample containing the cell-free plasma DNA from the patient, to the patient-specific genomic reference graph to identify a second population of one or more mutations in the cell-free plasma DNA relative to the at least one non-tumor sequence from the patient, wherein the first sample was obtained at a first time and the second sample was obtained at a second time after the first time;
- generating a report indicating a comparison between the first population of one or more mutations and the second population of one or more mutations.
The system of claim 16, wherein:
- a first path through the patient-specific genomic reference graph represents a tumor-associated mutation, and
- the method further comprises:
- determining, based on the aligning of the first set of sequence reads to the patient-specific genomic reference graph, a proportion of the first set of sequence reads aligned to the first path.
Dependencies are inferred from the claim text.